Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
Zohreh Amoozgar, Jonas Kloepper, Jun Ren, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
Yan Tie, Fan Tang, Yuquan Wei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 306
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
Christopher Tay, Atsushi Tanaka, Shimon Sakaguchi
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 450-465
Open Access | Times Cited: 259
Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106
Immunotherapy of Cancer by Targeting Regulatory T cells
Bo-Jin Chen, Jingwen Zhao, Dahong Zhang, et al.
International Immunopharmacology (2022) Vol. 104, pp. 108469-108469
Open Access | Times Cited: 76
Radiation-induced tumor immune microenvironments and potential targets for combination therapy
Siyu Guo, Yihan Yao, Yang Tang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 69
Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice
Xinyue Dong, Jun Ren, Zohreh Amoozgar, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 3, pp. e005583-e005583
Open Access | Times Cited: 57
CD103+ regulatory T cells underlie resistance to radio-immunotherapy and impair CD8+ T cell activation in glioblastoma
Luuk van Hooren, Shanna M. Handgraaf, Daan J. Kloosterman, et al.
Nature Cancer (2023) Vol. 4, Iss. 5, pp. 665-681
Open Access | Times Cited: 52
Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction
Lanqi Gong, Jie Luo, Yu Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 43
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance
Xiaoting Zhou, Yanghong Ni, Xiao Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 52
Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment
Bayley McRitchie, Billur Akkaya
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM
Bao Liu, Qifeng Ji, Ying Cheng, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 39
Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models
Meenal Datta, Sampurna Chatterjee, Elizabeth M. Perez, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 6
Open Access | Times Cited: 31
Roles of STAT3 in the pathogenesis and treatment of glioblastoma
Weijia Fu, Xue Hou, Lihua Dong, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 30
Cancer cell plasticity and MHC-II–mediated immune tolerance promote breast cancer metastasis to lymph nodes
Pin‐Ji Lei, Ethel R. Pereira, Patrik Andersson, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 9
Open Access | Times Cited: 27
Antibody-based cancer immunotherapy by targeting regulatory T cells
Quanxiao Li, Jun Lu, Jinyao Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 23
Brain regulatory T cells
Adrian Liston, Emanuela Pasciuto, Denise Fitzgerald, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 326-337
Closed Access | Times Cited: 23
FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer
Haiyang Li, Na Zheng, Anning Guo, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 9
Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population
Anthony Z. Wang, Bryce L. Mashimo, Maximilian O. Schaettler, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 1106-1131
Closed Access | Times Cited: 9
MAPK and STAT3 Inhibitors Modulate FoxP3 Expression and Regulatory T Cell Function
Nuria García‐Díaz, Elise Solli, Ehsan Hajjar, et al.
European Journal of Immunology (2025) Vol. 55, Iss. 2
Closed Access | Times Cited: 1
Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade
Michael Dixon, Lin Luo, Sadashib Ghosh, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 43
Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma
Lizhi Pang, Fatima Khan, Amy B. Heimberger, et al.
Trends in cancer (2022) Vol. 8, Iss. 10, pp. 839-854
Open Access | Times Cited: 37
The immunosuppressive microenvironment and immunotherapy in human glioblastoma
Xuehua Zhang, Leilei Zhao, He Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
CAR T Cell Locomotion in Solid Tumor Microenvironment
Duy Nguyen, Elizabeth Ogando‐Rivas, Ruixuan Liu, et al.
Cells (2022) Vol. 11, Iss. 12, pp. 1974-1974
Open Access | Times Cited: 32
Reprogramming the tumor microenvironment with biotechnology
Minjeong Kim, Na Kyeong Lee, Chi‐Pin James Wang, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top